WilliamJosephBurkeMD

PubMed

• Human-Animal Chimera Formation for Organ Transplantation: Subjugating Human Embryonic Development to Animal Control.
  Patrick Pullicino, Edward J Richard, William J Burke> ;The Linacre Quarterly. 2023 May 1
• 2 citations
  Mass Production of Human "Embryoid" Cells from Developmentally Frozen Embryos: Is It Ethical?
  Patrick Pullicino, Edward J Richard, William J. Burke> ;The Linacre Quarterly. 2020 May 22
• 17 citations
  Aldehyde adducts inhibit 3,4-dihydroxyphenylacetaldehyde-induced α-synuclein aggregation and toxicity: Implication for Parkinson neuroprotective therapy.
  Vijaya B. Kumar, Fong-Fu Hsu, Vijaya M. Lakshmi, Kathleen N. Gillespie, William J. Burke> ;European Journal of Pharmacology. 2019 Feb 15
• 49 citations
  Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson diseaseAuthor Response
  William J. Burke, Jeff M. Bronstein, Arthur G. Fitzmaurice> ;Neurology. 2014 Nov 11
• 97 citations
  The neurotoxicity of DOPAL: behavioral and stereological evidence for its role in Parkinson disease pathogenesis.
  W. Michael Panneton, Vijaya B. Kumar, Qi Gan, William J. Burke, James E. Galvin> ;Plos One. 2010 Dec 13
• 1 citations
  ASSOCIATION OF ANOSMIA WITH AUTONOMIC FAILURE IN PARKINSON DISEASE
  William J. Burke> ;Neurology. 2010 Jul 6
• 1 citations
  BEATING A DEAD HORSE: DOPAMINE AND PARKINSON DISEASE
  William J. Burke> ;Neurology. 2008 May 27
• 168 citations
  Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine.
  William J. Burke, Vijaya B. Kumar, Neeraj Pandey, W. Michael Panneton, Qi Gan, Mark Franko, Mark A. O'Dell, Shu Wen Li, Yi Pan, Hyung D. Chung, James E. Galvin> ;Acta Neuropathologica. 2008 Feb 1
• The progression of Parkinson disease: a hypothesis.
  Burke WJ> ;Neurology. 2007-08-14
• Neuroprotective agents for clinical trials in ALS: systematic assessment.
  Burke WJ> ;Neurology. 2007-02-27
• A critique of oocyte-assisted reprogramming.
  William J. Burke, Patrick M. Pullicino, Edward J Richard> ;The National Catholic Bioethics Quarterly. 2006 Jan 1
• Stemming the tide of cloning.
  William J. Burke, Patrick Pullicino, Edward J. Richard, Maureen Condic> ;First Things. 2005 Dec 1
• 145 citations
  Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: role in neurodegenerative diseases.
  William J. Burke, Shu Wen Li, Hyung D. Chung, David A. Ruggiero, Bruce S. Kristal, Eugene M. Johnson, Patricia A. Lampe, Vijaya B. Kumar, Mark Franko, Evelyn A. Willia...> ;Neurotoxicology. 2004 Jan 1
• 143 citations
  3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis.
  William J. Burke, Shu Wen Li, Evelyn A. Williams, Randal Nonneman, Daniel S. Zahm> ;Brain Research. 2003 Nov 7
• 41 citations
  3,4-dihydroxyphenylacetaldehyde: a potential target for neuroprotective therapy in Parkinson's disease.
  Burke Wj> ;Current Drug Targets. CNS and Neurological Disorders. 2003 Mar 31
• 72 citations
  3,4-Dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: possible role in Parkinson's disease pathogenesis.
  Shu Wen Li, Tien-Sung Lin, Shelly D. Minteer, William J. Burke> ;Brain Research. Molecular Brain Research. 2001 Sep 10
• 104 citations
  Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria.
  Bruce S. Kristal, Ann D. Conway, Abraham M. Brown, Jinesh C. Jain, Paul A Ulluci, Shu Wen Li, William J. Burke> ;Free Radical Biology & Medicine. 2001 Apr 15
• 24 citations
  Catecholamine monoamine oxidase a metabolite in adrenergic neurons is cytotoxic in vivo.
  William J. Burke, Shu Wen Li, Daniel S. Zahm, Heather Macarthur, Lacy L. Kolo, Thomas C. Westfall, Muhammad Anwar, Sara B. Glickstein, David A. Ruggiero> ;Brain Research. 2001 Feb 9
• 1 citations
  Withdrawal of life support in the neurologic intensive care unit
  Patrick M. Pullicino, William J. Burke> ;Neurology. 1999 Dec 1
• 33 citations
  Quantitation of 3,4-dihydroxyphenylacetaldehyde and 3, 4-dihydroxyphenylglycolaldehyde, the monoamine oxidase metabolites of dopamine and noradrenaline, in human tissu...
  William J. Burke, Hyung D. Chung, Shu Wen Li> ;Analytical Biochemistry. 1999 Aug 15
• 15 citations
  Treating Visual Hallucinations With Donepezil
  William J. Burke, William H. Roccaforte, Steven P. Wengel> ;The American Journal of Psychiatry. 1999 Jul 1
• 53 citations
  Accumulation of 3,4-dihydroxyphenylglycolaldehyde, the neurotoxic monoamine oxidase A metabolite of norepinephrine, in locus ceruleus cell bodies in Alzheimer's diseas...
  William J. Burke, Shu Wen Li, Catherine A. Schmitt, Ping Xia, Hyung D. Chung, Kathleen N Gillespie> ;Brain Research. 1999 Jan 23
• 12 citations
  Behavioral complications associated with donepezil.
  Steven P. Wengel, William H. Roccaforte, William J. Burke, Barbara L. Bayer, Dennis P. McNeilly, Debra Knop> ;The American Journal of Psychiatry. 1998 Nov 1
• 42 citations
  Norepinephrine transmitter metabolite generates free radicals and activates mitochondrial permeability transition: a mechanism for DOPEGAL-induced apoptosis
  William J. Burke, Bruce S. Kristal, Byung Pal Yu, Shu Wen Li, Tien-Sung Lin> ;Brain Research. 1998 Mar 23
• 18 citations
  Norepinephrine transmitter metabolite induces apoptosis in differentiated rat pheochromocytoma cells.
  William J. Burke, Catherine A. Schmitt, Chyien Miller, Shu Wen Li> ;Brain Research. 1997 Jun 20
• Join now to see all